Treatment landscape of metastatic prostate cancer: the role of radium-223.
(2017) Acta Clinica Belgica — Vol. 72, n° 1, p. 19-23 (2016)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- The landscape of metastatic prostate cancer has changed recently with the availability of six new molecules showing an overall survival benefit. The development of compounds able to decrease the rate of complications from bone metastasis has also led to improvements in overall morbidity associated with this disease. In this paper, we briefly review the currently available drugs indicated in the treatment of metastatic prostate cancer, focusing on the place of the radiopharmaceutical agent radium-223 and its very unique mechanism of action and safety profile.
- Affiliations
Citations
Dermine, A., & Machiels, J.-P. (2017). Treatment landscape of metastatic prostate cancer: the role of radium-223. Acta Clinica Belgica, 72(1), 19-23. https://doi.org/10.1080/17843286.2016.1203545 (Original work published 2016)